Search results for "reparation"

showing 10 items of 944 documents

Enhanced antifungal efficacy of tebuconazole using gated pH-driven mesoporous nanoparticles

2014

Núria Mas,1–3 Irene Galiana,3 Silvia Hurtado,† Laura Mondragón,1–3 Andrea Bernardos,1–3 Félix Sancenón,1–3 María D Marcos,1–3 Pedro Amorós,4 Nuria Abril-Utrillas,5 Ramón Martínez-Máñez,1–3 José Ramón Murguía1,3 1Centro de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Centro Mixto Universidad Politécnica de Valencia, Universidad de Valencia, Valencia, Spain; 2Departamento de Química, Universidad Politécnica de Valencia, Valenci…

INGENIERIA DE LA CONSTRUCCIONMaterials scienceAntifungal AgentsPH-responsive nanoparticlesCell Survivalmedia_common.quotation_subjectCapped mesoporous nanoparticlesBiophysicsPharmaceutical ScienceNanoparticleBioengineeringSaccharomyces cerevisiaeNanocapsulesBiomaterialsDiffusionchemistry.chemical_compoundNanoporesQUIMICA ORGANICANanocapsulesInternational Journal of NanomedicineDrug DiscoveryQUIMICA ANALITICABIOQUIMICA Y BIOLOGIA MOLECULARFluoresceinParticle SizeCytotoxicityInternalizationmedia_commonTebuconazoleOriginal ResearchIntracellular releaseOrganic ChemistryQUIMICA INORGANICADrug SynergismGeneral MedicineMesoporous silicaHydrogen-Ion ConcentrationTriazoleschemistryBiochemistryDelayed-Action PreparationsBiophysicsTebuconazole loadingMesoporous materialPorosityInternational Journal of Nanomedicine
researchProduct

Enzyme-Responsive Intracellular Controlled Release Using Nanometric Silica Mesoporous Supports Capped with "Saccharides"

2010

The synthesis of new capped silica mesoporous nanoparticles for on-command delivery applications is described. The gate-like functional hybrid systems consisted of nanoscopic MCM-41-based materials functionalized on the pore outlets with different “saccharide” derivatives and a dye contained in the mesopores. A series of hydrolyzed starch products as saccharides were selected. The mesoporous silica nanoparticles S1, S2, and S3 containing the grafted starch derivatives Glucidex 47, Gludicex 39, and Glucidex 29 were synthesized. Additionally, for comparative purposes solid S4 containing lactose was prepared. Delivery studies in pure water in the presence of pancreatin or -D-galactosidase were…

INGENIERIA DE LA CONSTRUCCIONMaterials scienceTECNOLOGIA DE ALIMENTOSSwineStarchIntracellular SpaceCarbohydratesGatecarbohydratesGeneral Physics and AstronomyNanoparticleMesoporousKluyveromycesHydrolysischemistry.chemical_compoundAdsorptionQUIMICA ORGANICAgateAnimalsHumansOrganic chemistryGeneral Materials ScienceDrug CarriersQUIMICA INORGANICAGeneral EngineeringMesoporous silicaSilicon Dioxidebeta-GalactosidaseControlled releaseNanostructuresIntracellular controlled releaseMesoporous organosilicaenzymechemistryChemical engineeringEnzymeDelayed-Action Preparationsintracellular controlled releaseLLC-PK1 CellsAdsorptionMesoporous materialmesoporousPorosityHeLa Cells
researchProduct

A lab in the field: applications of real-time, in situ metagenomic sequencing

2020

High-throughput metagenomic sequencing is considered one of the main technologies fostering the development of microbial ecology. Widely used second-generation sequencers have enabled the analysis of extremely diverse microbial communities, the discovery of novel gene functions, and the comprehension of the metabolic interconnections established among microbial consortia. However, the high cost of the sequencers and the complexity of library preparation and sequencing protocols still hamper the application of metagenomic sequencing in a vast range of real-life applications. In this context, the emergence of portable, third-generation sequencers is becoming a popular alternative for the rapi…

In situ metagenomics0303 health sciences030306 microbiologyComputer scienceLibrary preparationin situ metagenomicsContext (language use)Third generation sequencingReviewmicrobial ecologyData scienceGeneral Biochemistry Genetics and Molecular BiologyField (computer science)Microbial ecologyNovel gene03 medical and health sciencesMicrobial ecologyMetagenomicsClinical diagnosisAcademicSubjects/SCI00960General Agricultural and Biological Sciencesthird-generation sequencingThird-generation sequencing030304 developmental biologyBiology Methods & Protocols
researchProduct

In Situ Perfusion Model in Rat Colon for Drug Absorption Studies: Comparison with Small Intestine and Caco-2 Cell Model.

2015

Our aim is to develop and to validate the in situ closed loop perfusion method in rat colon and to compare with small intestine and Caco-2 cell models. Correlations with human oral fraction absorbed (Fa) and human colon fraction absorbed (Fa_colon) were developed to check the applicability of the rat colon model for controlled release (CR) drug screening. Sixteen model drugs were selected and their permeabilities assessed in rat small intestine and colon, and in Caco-2 monolayers. Correlations between colon/intestine/Caco-2 permeabilities versus human Fa and human Fa_colon have been explored to check model predictability and to apply a BCS approach in order to propose a cut off value for CR…

In situAbsorption (pharmacology)MalePathologymedicine.medical_specialtyColonCellPharmaceutical SciencePermeabilityCell Line TumorIntestine SmallmedicineAnimalsHumansRats Wistarbusiness.industryBiological TransportControlled releaseMolecular biologydigestive system diseasesSmall intestineRatsPerfusionmedicine.anatomical_structureIntestinal AbsorptionCaco-2Paracellular transportDelayed-Action PreparationsModels AnimalCaco-2 CellsbusinessPerfusionJournal of pharmaceutical sciences
researchProduct

In situ formation of steroidal supramolecular gels designed for drug release

2013

In this work, a steroidal gelator containing an imine bond was synthesized, and its gelation behavior as well as a sensitivity of its gels towards acids was investigated. It was shown that the gels were acid-responsive, and that the gelator molecules could be prepared either by a conventional synthesis or directly in situ during the gel forming process. The gels prepared by both methods were studied and it was found that they had very similar macroand microscopic properties. Furthermore, the possibility to use the gels as carriers for aromatic drugs such as 5-chloro-8-hydroxyquinoline, pyrazinecarboxamide, and antipyrine was investigated and the prepared two-component gels were studied with…

In situMagnetic Resonance SpectroscopykolesteroliImineSupramolecular chemistryPharmaceutical ScienceArticleChloroquinolinolsAnalytical ChemistryDelayed-Action Preparationslcsh:QD241-441chemistry.chemical_compoundgeeliDrug Delivery Systemslcsh:Organic chemistryDrug DiscoveryPolymer chemistryMoleculeddc:530Physical and Theoretical Chemistryta116drug releaseOrganic ChemistryorganogelcholesterolNuclear magnetic resonance spectroscopyacid-responsiveHydrogen-Ion ConcentrationchemistryChemistry (miscellaneous)in situ gelationDelayed-Action PreparationsDrug deliveryDrug releaseMolecular Medicineorganogel; acid-responsive; cholesterol; <i>in situ</i> gelation; drug releaseGels
researchProduct

In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluis…

2015

Intestinal drug permeability has been recognized as a critical determinant of the fraction dose absorbed, with direct influence on bioavailability, bioequivalence and biowaiver. The purpose of this research was to compare intestinal permeability values obtained by two different intestinal rat perfusion methods: the single-pass intestinal perfusion (SPIP) model and the Doluisio (closed-loop) rat perfusion method. A list of 15 model drugs with different permeability characteristics (low, moderate, and high, as well as passively and actively absorbed) was constructed. We assessed the rat intestinal permeability of these 15 model drugs in both SPIP and the Doluisio methods, and evaluated the co…

In situMaleSingle passIntestinal permeabilitybusiness.industryPharmaceutical ScienceBioequivalencePharmacologymedicine.diseaseBiopharmaceutics Classification SystemModels BiologicalPermeabilityBioavailabilityRatsPerfusionPermeability (earth sciences)Intestinal AbsorptionPharmaceutical PreparationsmedicineAnimalsHumansIntestinal MucosaRats WistarbusinessPerfusionInternational journal of pharmaceutics
researchProduct

Defining level A IVIVC dissolution specifications based on individual in vitro dissolution profiles of a controlled release formulation.

2018

Regulatory guidelines recommend that, when a level A IVIVC is established, dissolution specification should be established using averaged data and the maximum difference between AUC and Cmax between the reference and test formulations cannot be greater than 20%. However, averaging data assumes a loss of information and may reflect a bias in the results. The objective of the current work is to present a new approach to establish dissolution specifications using a new methodology (individual approach) instead of average data (classical approach). Different scenarios were established based on the relationship between in vitro-in vivo dissolution rate coefficient using a level A IVIVC of a cont…

In vitro dissolutionCmaxPharmaceutical Science02 engineering and technologyBioequivalence021001 nanoscience & nanotechnology030226 pharmacology & pharmacyControlled releaseModels Biological03 medical and health sciencesDrug Liberation0302 clinical medicineIVIVCTherapeutic EquivalencyDelayed-Action PreparationsMaximum differenceRange (statistics)Computer Simulation0210 nano-technologyBiological systemDissolutionMonte Carlo MethodMathematicsTabletsEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Crystal Structures and Magnetic Properties of Novel [LnIIICuII4] (Ln = Gd, Dy, Ho) Pentanuclear Complexes. Topology and Ferromagnetic Interaction in …

1996

The first pentanuclear complexes of formula {Dy[Cu(apox)](2)[Cu(apox)(H(2)O)](2)}[ClO(4)](3).7H(2)O (1), {Ho[Cu(apox)][Cu(apox)(H(2)O)](3)}[PF(6)](3).4.5H(2)O (2), {Gd[Cu(apox)](2)[Cu(apox)(H(2)O)](2)}[ClO(4)](3).7H(2)O (3) and {Gd[Cu(apox)][Cu(apox) (H(2)O)](3)}[PF(6)](3).4.5H(2)O (4) (H(2)apox = N,N'-bis(3-aminopropyl)oxamide) have been synthesized. The crystal structures of complexes 1 and 2 have been determined by X-ray diffraction methods. Complexes 3 and 4 are isostructural with 1 and 2, respectively. Crystallographic data are as follows: 1 and 3, monoclinic, space group C2/c and Z = 4, with a = 14.646(6) Å, b = 29.496(7) Å, c = 16.002(7) Å, and beta = 111.76(2) degrees for 1 and a = …

Inorganic ChemistryCrystallographyFerromagnetismChemistryX-ray crystallographyChemical preparationCenter (category theory)Crystal structurePhysical and Theoretical ChemistryMagnetic susceptibilityInorganic Chemistry
researchProduct

Techniques To Control Polymersome Size

2015

Polymersomes as synthetic analogues of liposomes appear frequently in relevant literature as promising candidates for a wide range of different applications including drug delivery, theranostic multitools, and nanoreactors. In particular, as nanotransporters for nanomedical applications in vivo, requirements concerning the reproducible manufacturing and reliable size control are extremely high. This Perspective highlights the importance of size control especially in the context of nanomedicine and gives an overview of the theoretical background of amphiphilic self-assembly leading to different preparation methods, where their feasibility of controlling polymersomes’ size is discussed.

Inorganic ChemistryPreparation methodPolymers and PlasticsComputer scienceOrganic ChemistryPolymersomeDrug deliveryMaterials ChemistryNanomedicineContext (language use)NanotechnologyMacromolecules
researchProduct

Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: state-of-the-science and expert consensus

2021

Vasopressors and inotropic agents are widely used in critical care. However, strong evidence supporting their use in critically ill patients is lacking in many clinical scenarios. Thus, the Italian Society of Anesthesia and Intensive Care (SIAARTI) promoted a project aimed to provide indications for good clinical practice on the use of vasopressors and inotropes, and on the management of critically ill patients with shock. A panel of 16 experts in the field of intensive care medicine and hemodynamics has been established. Systematic review of the available literature was performed based on PICO questions. Basing on available evidence, the panel prepared a summary of evidences and then wrote…

Inotropemedicine.medical_specialtyConsensusCritical CareCritical IllnessMEDLINEshockCardiotonic AgentsCardiotonic agentsVasoconstrictor agentsCardiogenic shock; Cardiotonic agents; Septic shock; Vasoconstrictor agents03 medical and health sciences0302 clinical medicineVasoconstrictor agents030202 anesthesiologySeptic shockIntensive caremedicineHumansVasoconstrictor AgentsIntensive care medicineCardiogenic shockbusiness.industrySeptic shockCardiogenic shock030208 emergency & critical care medicinemedicine.diseaseAnesthesiology and Pain MedicinePharmaceutical PreparationsShock (circulatory)Good clinical practicemedicine.symptombusinessCardiotonic agents
researchProduct